---
title: 'Prognostic value of Alzheimer''s disease plasma biomarkers in the oldest-old:
  a prospective primary care-based study'
date: '2024-09-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39253733/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240910182418&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Blood-based biomarkers offer a promising, less invasive,
  and more cost-effective alternative for Alzheimer''s disease screening compared
  to cerebrospinal fluid or imaging biomarkers. However, they have been extensively
  studied only in memory clinic-based cohorts. We aimed to validate them in a more
  heterogeneous, older patient population from primary ...'
disable_comments: true
---
BACKGROUND: Blood-based biomarkers offer a promising, less invasive, and more cost-effective alternative for Alzheimer's disease screening compared to cerebrospinal fluid or imaging biomarkers. However, they have been extensively studied only in memory clinic-based cohorts. We aimed to validate them in a more heterogeneous, older patient population from primary ...